Search Results
You are looking at 1 - 4 of 4 items for
- Author: S. BALSAN x
- Refine by access: All content x
Search for other papers by H. PAVLOVITCH in
Google Scholar
PubMed
Search for other papers by O. FONTAINE in
Google Scholar
PubMed
Search for other papers by S. BALSAN in
Google Scholar
PubMed
The metabolism of 25-hydroxycholecalciferol (25-(OH)D3) was investigated in rats fed a diet low in calcium and without vitamin D for 4 weeks after hypophysectomy. Compared with intact rats on the same diet these animals had a low serum phosphorus concentration, a less marked degree of hypocalcaemia and their parathyroid gland was not hypertrophied. Eighteen hours after i.p. injection of a single dose of tritiated 25-(OH)D3, chromatography of serum extracts on Sephadex LH-20 showed that the percentage of radioactivity corresponding to 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) was lower in hypophysectomized rats than in control rats. High-pressure liquid chromatography demonstrated that 81% of this material had the same elution profile as synthetic 1,25-(OH)2D3. The percentage of 1,25-(OH)2D3 in the serum of hypophysectomized rats could be increased to the level seen in the controls by chronic treatment with bovine growth hormone. This action of growth hormone was most probably independent of the parathyroid glands since the injection of parathyroid extract did not alter 25-(OH)D3 metabolism in hypophysectomized animals. These results suggest that the decrease in the conversion of 25-(OH)D3 to 1,25-(OH)2D3 after hypophysectomy may be related to the lack of growth hormone.
Search for other papers by B. Escoubet in
Google Scholar
PubMed
Search for other papers by C. Silve in
Google Scholar
PubMed
Search for other papers by S. Balsan in
Google Scholar
PubMed
Search for other papers by C. Amiel in
Google Scholar
PubMed
ABSTRACT
It is accepted that renal phosphate wasting is the basis of hypophosphataemia in vitamin D-resistant hypophosphataemic rickets (VDRR). Abnormal renal adaptation to phosphate deprivation has also been reported in these patients. We studied sodium-dependent phosphate transport and its modulation by phosphate deprivation in skin fibroblasts cultured from healthy subjects and patients with VDRR. Control fibroblasts exhibited high-affinity sodium-dependent phosphate transport (77 ± 12 μmol/l) which resembled the ubiquitous transport of renal and non-renal cells. Phosphate deprivation (incubation in low phosphate medium) increased the maximal velocity (V max) of the transport by 2·7-fold after 24 h, with no change in the affinity. The increase in V max was dependent on gene transcription and protein synthesis. The sodium-dependent phosphate transport exhibited in fibroblasts from VDRR patients did not significantly differ from that of control subjects, except that the V max of the phosphate transport was higher in cells from patients with VDRR under normal and phosphate-deprivation conditions, although the difference was significant only after 24 h of phosphate deprivation (V max: 22·6 ± 2·4 pmol/mg protein per s in VDRR vs 16 ± 3·6 pmol/mg protein per s in controls, P < 0·05).
These data demonstrate that sodium-coupled phosphate transport in human skin fibroblasts has the properties of ubiquitous sodium-phosphate co-transport and show that this transport is not deficient in patients with VDRR. Indeed paradoxically the V max was 40% higher in VDRR than in control subjects after 24 h of phosphate deprivation. The transport must be either different from that of kidney cells responsible for the phosphate leak, or differently modulated. Therefore, skin fibroblasts cannot be used to determine the molecular defect responsible for the renal phosphate leak in VDRR patients.
Journal of Endocrinology (1992) 133, 301–309
Search for other papers by T. M. Nguyen in
Google Scholar
PubMed
Search for other papers by A. Halhali in
Google Scholar
PubMed
Search for other papers by H. Guillozo in
Google Scholar
PubMed
Search for other papers by M. Garabedian in
Google Scholar
PubMed
Search for other papers by S. Balsan in
Google Scholar
PubMed
ABSTRACT
The effect of thyroparathyroidectomy (TPTX) on the plasma concentrations of the vitamin D metabolites (25-(OH)D, 24,25-(OH)2D and 1,25-(OH)2D) has been studied in pregnant rats and their fetuses during the last quarter of gestation.
Maternal and fetal vitamin D metabolites were not significantly affected by TPTX. A significant increase in plasma 1,25-(OH)2D concentrations was observed in both TPTX and control mothers and fetuses from days 19 to 21. Fetal and maternal plasma 25-(OH)D were positively correlated in both control and TPTX groups. Such a correlation was also found for 24,25-(OH)2D in the two groups. In contrast, a positive correlation between maternal and fetal plasma concentrations of 1,25-(OH)2D was found in TPTX but not in control rats.
These data suggest that major alterations in calcium metabolism, such as that produced by maternal TPTX, are insufficient to affect the changes in maternal and fetal plasma 1,25-(OH)2D during late pregnancy significantly. They also suggest that parathyroid hormone, thyroxine, and/or calcitonin may control a possible placental transfer of 1,25-(OH)2D in the rat.
J. Endocr. (1988) 116, 381–385
Search for other papers by H. PAVLOVITCH in
Google Scholar
PubMed
Search for other papers by T. L. CLEMENS in
Google Scholar
PubMed
Search for other papers by D. LAOUARI in
Google Scholar
PubMed
Search for other papers by J. L. H. O'RIORDAN in
Google Scholar
PubMed
Search for other papers by S. BALSAN in
Google Scholar
PubMed
The metabolism of 25-hydroxycholecalciferol (25-(OH)D3), plasma concentration of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) and the amount of calcium-binding protein (CaBP) in duodenal mucosa were determined in ovariectomized rats and were compared with data observed in normal age-matched cyclic rats. Sephadex LH-20 and high-pressure liquid chromatography were used for the study of the metabolism of 25-(OH)D3. The concentration of 1,25-(OH)2D3 in plasma and prolactin in serum were measured by radioimmunoassay. Calcium-binding protein in duodenal mucosa was determined immunologically using electroimmunodiffusion. The results showed that the lack of ovarian hormones and low prolactin levels observed in ovariectomized rats did not promote a significant change in the metabolism of 25-(OH)D3, in the levels of 1,25-(OH)2D3 in the circulation or in the amount of CaBP in duodenal mucosa. It is possible that the regulation of 25-(OH)D3 by sex hormones is restricted to the state of calcium stress such as during egg-laying in birds or pregnancy and lactation in mammals.
